Find Patient Assistance

Answer a few simple questions to find out which patient assistance option might be right for your patient.

  • Is your patient insured?

  • Does your patient have commercial insurance?

    What does this mean?
  • Has your patient already been referred to the Rituxan Immunology Co-pay Card Program and is either ineligible or no longer receiving assistance?

  • Has your patient already been referred to an independent co-pay assistance foundation and is either ineligible or no longer receiving assistance?

  • Is the patient using Rituxan for an FDA-approved indication?

Your Patient Might Qualify for a Referral to the Rituxan Immunology Co-pay Card Program

If eligible commercially insured patients need assistance with their out-of-pocket costs, Genentech Rheumatology Access Solutions can refer them to the Rituxan Immunology Co-pay Card Program.*

 

Learn More

 

*In order to be eligible for the Rituxan Immunology Co-pay Card Program, the patient must have commercial insurance, must not have Medicare, Medicaid or other government insurance, and must meet other eligibility criteria. They must also agree to the rules set forth in the terms and conditions for the program. Please visit RACopay.com for the full list of terms and conditions.

Your Patient Might Qualify for a Referral to an Independent Co-pay Assistance Foundation

For eligible patients with commercial or public health insurance, Genentech Rheumatology Access Solutions offers referrals to independent co-pay assistance foundations.*

 

Learn More

 

*Genentech and Biogen do not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from Genentech Rheumatology Access Solutions. The foundations to which we refer patients are not exhaustive or indicative of Genentech’s or Biogen's endorsement or financial support. There may be other foundations to support the patient's disease state.

Your Patient Might Qualify for a Referral to the Genentech® Access to Care Foundation (GATCF)

GATCF helps eligible patients who meet specific criteria receive Rituxan free of charge.*

 

Learn More

 

*To be eligible for free Rituxan from GATCF, insured patients must have exhausted all other forms of patient assistance (including the Rituxan Immunology Co-pay Card Program and support from independent co-pay assistance foundations) and meet financial criteria. Uninsured patients must meet different financial criteria.

Patient Assistance Options

Referrals to the Rituxan Immunology Co-pay Card Program

Genentech Rheumatology Access Solutions can refer eligible patients to the Rituxan Immunology Co-pay Card Program for help with the out-of-pocket costs associated with Rituxan.*

Learn More

Referrals to Independent Co-pay Assistance Foundations

For eligible patients with commercial or public health insurance, Genentech Rheumatology Access Solutions offers referrals to independent co-pay assistance foundations.†

Learn More

Referrals to the Genentech® Access to Care Foundation (GATCF)

GATCF helps eligible patients who meet specific criteria receive Rituxan free of charge.‡

Learn More

*In order to be eligible for the Rituxan Immunology Co-pay Card Program, the patient must have commercial insurance, must not have Medicare, Medicaid or other government insurance, and must meet other eligibility criteria. They also must agree to the rules set forth in the terms and conditions for the program. Please visit RACopay.com for the full list of terms and conditions.

†Genentech and Biogen do not influence or control the operations or eligibility criteria of any independent co-pay assistance foundation and cannot guarantee co-pay assistance after a referral from Genentech Rheumatology Access Solutions. The foundations to which we refer patients are not exhaustive or indicative of Genentech's or Biogen’s endorsement or financial support. There may be other foundations to support the patient's disease state.

‡To be eligible for free medicine from GATCF, insured patients must have exhausted all other forms of patient assistance (including the Rituxan Immunology Co-pay Card Program and support from independent co-pay assistance foundations) and meet financial criteria. Uninsured patients must meet different financial criteria.

PAN=Patient Authorization and Notice of Request for Transmission of Health Information to Genentech Access Solutions and Genentech® Access to Care Foundation.

SMN=Statement of Medical Necessity.